The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Matervia
ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium citrate, iron, iodine · ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL 20 ug/1; THIAMINE MONONITRATE 1.4 mg/1; PYRIDOXAL 5-PHOSPHATE 2.5 mg/1; FOLIC ACID 1000 ug/1; METHYLCOBALAMIN 1000 ug/1; CALCIUM CITRATE 200 mg/1; IRON 13 mg/1; POTASSIUM IODIDE 150 ug/1 · Capsule · Oral · V2 Pharma LLC
NDC 72835-0660-01 · 60 CAPSULE in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- V2 Pharma, LLCUnited Stateslabel · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of ascorbic acid, cholecalciferol, thiamine, pyridoxal-5-phosphate, folic acid, methylcobalamin, calcium citrate, iron, iodine (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| V2 Pharma LLC | ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL 20 ug/1; THIAMINE MONONITRATE 1.4 mg/1; PYRIDOXAL 5-PHOSPHATE 2.5 mg/1; FOLIC ACID 1000 ug/1; METHYLCOBALAMIN 1000 ug/1; CALCIUM CITRATE 200 mg/1; IRON 13 mg/1; POTASSIUM IODIDE 150 ug/1 | Aug 26, 2026 | Sep 2, 2026 |
| V2 Pharma LLC | ASCORBIC ACID 125 mg/1; CHOLECALCIFEROL 200 mg/1; THIAMINE MONONITRATE 20 ug/1; PYRIDOXAL 5-PHOSPHATE 1000 ug/1; FOLIC ACID 13 mg/1; METHYLCOBALAMIN 1000 ug/1; CALCIUM CITRATE 150 ug/1; IRON 2.5 mg/1; POTASSIUM IODIDE 1.4 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| V2 Pharma LLC | ASCORBIC ACID 125 mg/1; CALCIUM CITRATE 200 mg/1; CHOLECALCIFEROL 20 ug/1; FOLIC ACID 1000 ug/1; IRON 13 mg/1; METHYLCOBALAMIN 1000 ug/1; POTASSIUM IODIDE 150 ug/1; PYRIDOXAL 5-PHOSPHATE 2.5 mg/1; THIAMINE MONONITRATE 1.4 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Matervia — NDC 72835-0660-01," retrieved September 3, 2026, https://drugdashboards.com/drug/72835066001.
Free to cite with attribution — see how the data is put together.